Pogue: The problem I have expeienced in the past with some other emerging biotechs is that I lost my position. What I mean by that is you never know when a promising biotech may break out on very positive news and move dramatically (Of course, it works in the reverse if he news is very negative). Very positive news is usually FDA approval or news that makes it obvious there will be FDA approval, but it may be approval in Europe or elsewhere. Times are changing.
The mistake I have made in the past is to sell all of my position of an excellent biotech prospect only to see a dramatic move up aferwards. In other words, I lost my position at at crucial time. The moves upward (or downward) tend to be sudden, aburpt, and unexpected. Therefore, I, like many others on this board, am maintaining a core position in AVXL, and I buy and sell some shares as the share price cycles up and down. I try to buy trading shares well below my overall share price average, and I sell some or all of the trading shares above my share price average. I have owned AVXL stock for over 4 years, and there have been times I was down 35% or more. The stock has wide swings, but all emerging biotechs tend to be highly volitable. In any event, I now maintain a core position in promising biotech stocks like AVXL all the while trading some shares as well.
I do not want to become frustrated and lose my core position that I am holding for the long term; hopefully, for a dramatic move upwards at some point down the road. Frustration is an early stage of capitulation that may eventually cause you to give up at the wrong time.
I am not saying AVXL is a sure thing. It is not. No emerging biotech is. I have done and continue to do my DD, and I am holding the core position until I see the contrary handwriting on the wall if you know what I mean. Do your DD and decide for yourself if this is something you desire to own and maintain as a core position for as long it takes to either succeed or fail.
Good luck whatever you do.
